World's Best Scientists 2026 revealed!
Jo A. Van Ginderachter

Jo A. Van Ginderachter

D-Index & Metrics

Immunology

D-Index
63
Citations
24224
World Ranking
2977
National Ranking
40

Jo A. Van Ginderachter publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jo A. Van Ginderachter sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 202 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jo A. Van Ginderachter D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jo A. Van Ginderachter sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jo A. Van Ginderachter is affiliated with Vrije Universiteit Brussel in Belgium and contributes to research primarily in immunology and related biomedical fields. Their work spans immunology and microbiology, medicine, and biochemistry, genetics, and molecular biology. The scientist's research includes significant focus on subfields such as immunology, molecular biology, oncology, radiology, nuclear medicine, imaging, and neurology.

Their scholarly activities cover a range of topics including immune cells in cancer, immunotherapy and immune responses, immune cell function and interaction, monoclonal and polyclonal antibodies research, neuroinflammation and neurodegeneration mechanisms, cancer immunotherapy and biomarkers, and CAR-T cell therapy research.

Jo A. Van Ginderachter has published multiple papers in frequent collaboration with several coauthors. The most frequent coauthors include Damya Laoui, Yvon Elkrim, Daliya Kancheva, Kiavash Movahedi, and Benoît Stijlemans.

The scientist's publications often appear in notable venues such as Frontiers in Immunology, Cancers, Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), and SSRN Electronic Journal.

Representative recent papers include:

  • Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization, 2021, Nature Neuroscience
  • Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies, 2020, eLife
  • Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy, 2021, Journal for ImmunoTherapy of Cancer
  • Macrophages are metabolically heterogeneous within the tumor microenvironment, 2021, Cell Reports
  • Differential plasticity and fate of brain-resident and recruited macrophages during the onset and resolution of neuroinflammation, 2022, Immunity

Best Publications

  • Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines

    Peter J Murray;Judith E Allen;Subhra K Biswas;Edward A Fisher

  • Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity

    Kiavash Movahedi;Martin Guilliams;Jan Van den Bossche;Rafael Van den Bergh

  • Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes

    Kiavash Movahedi;Damya Laoui;Conny Gysemans;Martijn Baeten

  • A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment.

    Hannah Van Hove;Liesbet Martens;Isabelle Scheyltjens;Karen De Vlaminck

  • HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

    Charlotte Rolny;Massimiliano Mazzone;Sònia Tugues;Damya Laoui

  • Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity

    Andrea Casazza;Damya Laoui;Mathias Wenes;Sabrina Rizzolio

  • Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization.

    Ana Rita Pombo Antunes;Isabelle Scheyltjens;Francesca Lodi;Julie Messiaen

  • Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion.

    Jo A. Van Ginderachter;Kiavash Movahedi;Gholamreza Hassanzadeh Ghassabeh;Sofie Meerschaut

  • Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity

    Kim Vriens;Stefan Christen;Sweta Parik;Dorien Broekaert

  • Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population

    Damya Laoui;Eva Van Overmeire;Giusy Di Conza;Chiara Aldeni

  • Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions

    Damya Laoui;Kiavash Movahedi;Eva Van Overmeire;Jan Van den Bossche

  • Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages

    Kiavash Movahedi;Steve Schoonooghe;Damya Laoui;Isabelle Houbracken

  • Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity

    Xenia Geeraerts;Evangelia Bolli;Sarah-Maria Fendt;Jo A. Van Ginderachter

  • Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression.

    Manesh Chittezhath;Manprit Kaur Dhillon;Jyue Yuan Lim;Damya Laoui

  • The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.

    Damya Laoui;Jiri Keirsse;Yannick Morias;Eva Van Overmeire

  • The transcription factor ZEB2 is required to maintain the tissue-specific identities of macrophages

    Charlotte L. Scott;Charlotte L. Scott;Wouter T’Jonck;Liesbet Martens;Helena Todorov

  • Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.

    Ana Rita Pombo Antunes;Isabelle Scheyltjens;Johnny Duerinck;Bart Neyns

  • M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment

    Eva Van Overmeire;Benoît Stijlemans;Felix Heymann;Jiri Keirsse

  • Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression

    Damya Laoui;Eva Van Overmeire;Patrick De Baetselier;Jo A. Van Ginderachter

  • Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer

    Paweł Bieniasz-Krzywiec;Rosa Martín-Pérez;Manuel Ehling;Melissa García-Caballero

  • Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T-CELL suppressive activity

    Kiavash Movahedi;Martin Guiliams;Jan Van den Bossche;Rafael Van den Bergh

Frequent Co-Authors

Patrick De Baetselier
Patrick De Baetselier Vrije Universiteit Brussel
Geert Raes
Geert Raes Vrije Universiteit Brussel
Alain Beschin
Alain Beschin Vrije Universiteit Brussel
Stefan Magez
Stefan Magez Ghent University
Karin Vanderkerken
Karin Vanderkerken Vrije Universiteit Brussel
Karine Breckpot
Karine Breckpot Vrije Universiteit Brussel
Martin Guilliams
Martin Guilliams Ghent University
Thierry VandenDriessche
Thierry VandenDriessche Vrije Universiteit Brussel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various interdisciplinary healthcare careers. Many students interested in immunology also explore nursing due to its practical applications in patient care and disease management.

For those without a nursing background, there are excellent options like online nursing programs for non nurses, making it easier to transition into this growing field. These programs provide foundational knowledge while accommodating busy schedules.

If you seek a faster route into nursing, easiest accelerated nursing programs offer intensive curricula designed to get you into the workforce quickly. Similarly, easy lpn programs to get into provide streamlined entry points for licensed practical nurses aiming to build clinical expertise relevant to immunology.

For advanced practice roles, easiest np program options are ideal for those aiming to specialize further, combining immunological knowledge with direct patient care. These pathways complement immunology studies by broadening career potential in healthcare.

Best Scientists Citing Jo A. Van Ginderachter

Trending Scientists

Recently Published Articles